BRIEF published on 07/08/2024 at 16:20, 1 year 7 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million Acquisition Investment Biotech Immuno-oncology QARZIBA®
BRIEF published on 07/08/2024 at 16:20, 1 year 7 months ago APEIRON Biologics va être acquis par Ligand Pharmaceuticals pour 100 millions de dollars Acquisition Investissement Immuno-oncologie Biotechnologies QARZIBA®
PRESS RELEASE published on 07/08/2024 at 16:15, 1 year 7 months ago APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG to be Acquired by Ligand Pharmaceuticals for USD 100 Million. Ligand will also invest up to USD 4 million in APEIRON spin-off, invIOs Acquisition Immuno-oncology Biotech Company APEIRON Biologics AG Ligand Pharmaceuticals
Published on 02/20/2026 at 18:30, 16 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 1 minute ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 16 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 38 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 46 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 10 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 46 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 18 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
